Amgen Inc AMGN Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansions
Published on February 10, 2025
Amgen Inc (AMGN) recently held its Q4 2024 earnings call, where it highlighted robust revenue growth and strategic expansions. The company reported revenue surpassing estimates, reaching $9.1 billion, with non-GAAP EPS rising to 5.31. This strong performance has attracted the attention of dividend investors, who should not be too quick to buy the stock for its upcoming dividend. To make informed decisions, it is recommended to seek professional advice from Stocks Prognosis regarding the future movement of AMGen's stocks.
Investor opinions & comments
To leave a comment, you need to Login or Register.
FinanceFlo
February 13, 2025 at 14:18
I'm impressed with Amgen's Q4 earnings results. The surpassing revenue estimates and rise in non-GAAP EPS show the company's ability to deliver solid financial results
ProfitPiper
February 13, 2025 at 02:44
The strong performance of Amgen in Q4 raises some doubts for me. I'm concerned about whether this growth can be sustained in the long term
InvestorIan
February 11, 2025 at 21:02
Great news! I'm excited to see Amgen's robust revenue growth and strategic expansions. This demonstrates the company's strong performance and future potential
GrowthGina
February 11, 2025 at 20:03
I'm uncertain about Amgen's future prospects despite its strong Q4 performance. It is important to carefully evaluate the company's long-term strategic decisions before making any investment decisions
ChloeJames
February 11, 2025 at 19:19
While Amgen's Q4 earnings call highlights impressive results, I am skeptical about the sustainability of this growth. It would be wise to closely monitor the company's upcoming financial reports
JamesThomas
February 10, 2025 at 15:17
Amgen's strong Q4 performance makes me interested in investing. The company's revenue growth and strategic expansions indicate a promising future for its stock